Oliver A Cornely Selected Research

Length of Stay

12/2023	Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study.
10/2023	Questioning the 14-day dogma in candidemia treatment duration.
6/2023	Outpatient care concept and potential inpatient cost savings associated with the administration of dalbavancin - A real-world data and retrospective cost analysis.
6/2023	Health-economic modelling of cost savings due to the use of rezafungin based on a German cost-of-illness study of candidiasis.
2/2022	A cost of illness study of COVID-19 patients and retrospective modelling of potential cost savings when administering remdesivir during the pandemic "first wave" in a German tertiary care hospital.
6/2009	Invasive candidiasis and candidemia: from current opinions to future perspectives.
11/2007	A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
12/2003	Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case-control study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Oliver A Cornely Research Topics

Disease

65	Infections 05/2024 - 05/2002
49	Mycoses (Diseases, Fungus) 05/2024 - 05/2003
41	Invasive Fungal Infections 01/2024 - 05/2003
40	Neoplasms (Cancer) 12/2023 - 05/2002
36	COVID-19 01/2024 - 06/2020
33	Aspergillosis 05/2023 - 04/2004
29	Neutropenia 12/2023 - 05/2003
22	Clostridium Infections 07/2023 - 08/2012
18	Candidiasis (Moniliasis) 12/2023 - 10/2003
16	Invasive Candidiasis 03/2024 - 01/2007
14	Communicable Diseases (Infectious Diseases) 12/2023 - 10/2003
13	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2023 - 05/2003
13	Mucormycosis 03/2022 - 08/2013
12	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 12/2006
11	Hematologic Neoplasms (Hematological Malignancy) 01/2024 - 12/2003
11	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2018 - 01/2007
10	Fever (Fevers) 04/2023 - 05/2004
9	Sepsis (Septicemia) 03/2024 - 12/2003
6	Candidemia 03/2024 - 04/2019
6	Critical Illness (Critically Ill) 04/2022 - 10/2011
6	Diarrhea 10/2015 - 10/2008
5	Abscess 03/2024 - 10/2005
5	Invasive Pulmonary Aspergillosis 05/2020 - 01/2009
5	Febrile Neutropenia 03/2008 - 01/2004
4	Surgical Wound Infection 03/2024 - 12/2018
4	Leukemia 12/2023 - 05/2002
4	Lung Diseases (Lung Disease) 04/2023 - 04/2019
4	Body Weight (Weight, Body) 01/2023 - 10/2008
4	Virus Diseases (Viral Diseases) 01/2023 - 10/2003
4	Bacterial Infections (Bacterial Infection) 04/2022 - 01/2007
4	Diabetes Mellitus 12/2021 - 11/2016
4	Mucositis 06/2016 - 10/2008
3	Weight Loss (Weight Reduction) 10/2023 - 01/2021
3	Pneumonia (Pneumonitis) 07/2023 - 01/2021
3	Obesity 04/2023 - 01/2023
3	Lymphoma (Lymphomas) 03/2022 - 05/2002
3	Pulmonary Aspergillosis 01/2022 - 07/2015
3	Pain (Aches) 01/2022 - 08/2011
3	Intraabdominal Infections 01/2020 - 12/2015
3	Endocarditis 01/2019 - 08/2007
3	Vomiting 10/2014 - 10/2008
3	Zygomycosis (Phycomycosis) 06/2007 - 09/2006
2	Cryptococcosis 02/2024 - 01/2016

Drug/Important Bio-Agent (IBA)

35	posaconazole FDA Link 01/2024 - 01/2006
29	Voriconazole (Vfend)FDA LinkGeneric 12/2021 - 10/2005
21	Anti-Bacterial Agents (Antibiotics)IBA 07/2023 - 05/2002
20	liposomal amphotericin B FDA Link 01/2022 - 09/2004
19	Caspofungin (Cancidas)FDA Link 11/2023 - 09/2004
18	Fluconazole (Zonal)FDA LinkGeneric 04/2019 - 08/2006
16	isavuconazoleIBA 05/2023 - 04/2015
15	Vancomycin FDA LinkGeneric 05/2024 - 04/2012
15	EchinocandinsIBA 03/2024 - 03/2008
15	VaccinesIBA 12/2023 - 01/2018
15	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2022 - 05/2003
14	Antifungal AgentsIBA 12/2023 - 04/2008
12	FidaxomicinIBA 05/2024 - 04/2012
12	AzolesIBA 12/2023 - 05/2003
12	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 05/2003
8	Antiviral Agents (Antivirals)IBA 10/2023 - 09/2015
8	Itraconazole (Sporanox)FDA LinkGeneric 01/2018 - 12/2006
8	Micafungin (FK463)FDA Link 12/2015 - 08/2006
6	AntigensIBA 12/2023 - 09/2009
6	galactomannanIBA 01/2022 - 04/2004
6	TabletsIBA 01/2018 - 05/2004
5	Biomarkers (Surrogate Marker)IBA 11/2023 - 09/2017
5	TriazolesIBA 05/2022 - 08/2006
5	EnzymesIBA 01/2022 - 04/2004
5	Sodium Glutamate (Accent)IBA 09/2019 - 03/2008
5	LipidsIBA 01/2019 - 12/2006
4	AntibodiesIBA 11/2023 - 09/2015
4	Monoclonal AntibodiesIBA 01/2023 - 05/2004
4	SteroidsIBA 01/2023 - 09/2014
4	bezlotoxumabIBA 10/2020 - 01/2017
3	RezafunginIBA 11/2023 - 01/2023
3	remdesivirIBA 04/2023 - 01/2022
3	Antineoplastic Agents (Antineoplastics)IBA 11/2020 - 11/2009
3	Anidulafungin FDA Link 04/2019 - 01/2007
3	Flucytosine (Ancobon)FDA Link 11/2018 - 12/2013
3	PolyenesIBA 12/2006 - 05/2003
2	Immunoglobulin G (IgG)IBA 02/2024 - 01/2021
2	midostaurinIBA 01/2024 - 07/2020
2	ProdrugsIBA 11/2023 - 07/2016
2	nirmatrelvir and ritonavir drug combinationIBA 10/2023 - 04/2023

Therapy/Procedure

66	Therapeutics 03/2024 - 05/2003
34	Drug Therapy (Chemotherapy) 12/2023 - 05/2003
22	Stem Cell Transplantation 12/2023 - 07/2005
11	Critical Care (Surgical Intensive Care) 01/2021 - 12/2003
10	Transplantation 01/2023 - 12/2006
8	Length of Stay 12/2023 - 12/2003
8	Hematopoietic Stem Cell Transplantation 01/2023 - 10/2005
7	Organ Transplantation 12/2023 - 10/2005
7	Remission Induction 11/2023 - 01/2008
7	Central Venous Catheters 02/2022 - 10/2003
6	Catheters 12/2023 - 05/2002
5	Induction Chemotherapy 01/2010 - 01/2006
4	Aftercare (After-Treatment) 02/2024 - 05/2004
4	Debridement 10/2019 - 08/2013
3	Salvage Therapy 01/2015 - 01/2006
2	Total Parenteral Nutrition 12/2023 - 01/2008
2	Duration of Therapy 10/2023 - 05/2020